\n\n\n\n\t\t\n\t\t\tNeurogesX\n\t\t\thttp://www.neurogesx.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tNeurogesX is a privately held specialty pharmaceutical company focusing on the development of products for the treatment of nerve signaling disorders. The company\'s initial products are focused on the...More»
\n\t\t\tNeurogesX is a privately held specialty pharmaceutical company focusing on the development of products for the treatment of nerve signaling disorders. The company\'s initial products are focused on the treatment of chronic and acute pain. The company will also apply its basic science and clinical expertise in neurobiology to develop treatments for non-pain indications caused by aberrant nerve signaling. NeurogesX\'s product strategy focuses on the rapid development of improved chemical entities. That is, all of NeurogesX\u2019s early projects involve known drug substances whose efficacy and/or side-effect profile can be improved upon in a proprietary way. The first product NGX-4010 seeks to exploit the well known, pain-relieving effects of topical capsaicin (the pungent ingredient in chili peppers).
(NASDAQ: NGSX)«Less
Overview
\n\t\t\t\tLocation: \tSan Carlos, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tbiotech,\n\t\t\t\tnerve,\n\t\t\t\tpain,\n\t\t\t\tdisorders,\n\t\t\t\tpharmaceutical,\n\t\t\t\tneurogesx,\n\t\t\t\tchronic,\n\t\t\t\tsignaling,\n\t\t\t\tacute\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series D - $3.33M (03/31/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tAlta Partners,\n\t\t\t\t\t\n\t\tArch Venture Partners,\n\t\t\t\t\t\n\t\tDiamond Capital Management,\n\t\t\t\t\t\n\t\tGlobal Life Science Ventures,\n\t\t\t\t\t\n\t\tMC Life Sciences Ventures,\n\t\t\t\t\t\n\t\tMontreaux Equity Partners,\n\t\t\t\t\t\n\t\tMunMun International,\n\t\t\t\t\t\n\t\tSaudi Venture Development,\n\t\t\t\t\t\n\t\tTIAA-Cref,\n\t\t\t\t\t\n\t\tWalden International,\n\t\t\t\t\t\n\t\tUniversity of North Carolina\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tTraversa,\n\t\t\t\t\tApplied Spine Technologies,\n\t\t\t\t\tUrigen Pharmaceuticals,\n\t\t\t\t\tSpinal Restoration,\n\t\t\t\t\tZogenix,\n\t\t\t\t\tMarinus Pharmaceuticals,\n\t\t\t\t\tDURECT,\n\t\t\t\t\tEKR Therapeutics,\n\t\t\t\t\tComplianceOnline,\n\t\t\t\t\tRoxro Pharma\n\t\t\t\t
\n\t\t\t